Ліпоарабіноманнановий тест бокового зсуву (тест сечі LF-LAM) для діагностики туберкульозу в осіб, що живуть з вірусом імунодефіциту людини (ВІЛ). Оновлення політики (2019)
Анотація
-Посилання
The End TB Strategy: global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva: World Health Organization; 2014 (https://www.who.int/tb/strategy/End_ TB_Strategy.pdf).
Global tuberculosis report 2018. Geneva: World Health Organization; 2018 (https://www.who. int/tb/publications/global_report/Main_text_21Sept2018_v1.1.pdf?ua=1).
Brennan PJ. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis. 2003;83(1–3):91–7 (http://dx.doi.org/10.1016/s1472-9792(02)00089-6).
Briken V, Porcelli SA, Besra GS, Kremer L. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol Microbiol. 2004;53(2):391–403 (http://dx.doi.org/10.1111/j.1365-2958.2004.04183.x).
Shah M, Martinson NA, Chaisson RE, Martin DJ, Variava E, Dorman SE. Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis. J Clin Microbiol. 2010;48(8):2972–4 (http://dx.doi.org/10.1128/jcm.00363-10).
Lawn SD, Gupta-Wright A. Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications. Trans R Soc Trop Med Hyg. 2016;110(3):180–5 (http://dx.doi.org/10.1093/trstmh/trw008).
Minion J, Leung E, Talbot E, Dheda K, Pai M, Menzies D. Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. Eur Respir J. 2011;38(6):1398–405 (http://dx.doi.org/10.1183/09031936.00025711).
Alere Determine™ TB LAM Ag: Rapid rule-in TB-HIV co-infection [website]. Abbott; 2019 (https://www.alere.com/en/home/product-details/determine-tb-lam.html).
The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV: Policy update. Geneva: World Health Organization; 2015 (https://www.who.int/tb/publications/use-of-lf-lam-tb-hiv/en/).
Shah M, Hanrahan C, Wang ZY, Dendukuri N, Lawn SD, Denkinger CM et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV‐positive adults. Cochrane Database Syst Rev. 2016;(5) (https://www.ncbi.nlm.nih.gov/pubmed/27163343).
Whiting PF. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529 (http://dx.doi.org/10.7326/0003-4819-155-8- 201110180-00009).
Peter J, Theron G, Chanda D, Clowes P, Rachow A, Lesosky M et al. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing. BMC Infect Dis. 2015;15(1) (http://dx.doi.org/10.1186/s12879-015-0967-z).
Peter JG, Theron G, van Zyl-Smit R, Haripersad A, Mottay L, Kraus S et al. Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J. 2012;40(5):1211–20 (http://dx.doi.org/10.1183/09031936.00201711).
Peter JG, Zijenah LS, Chanda D, Clowes P, Lesosky M, Gina P et al. Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial. Lancet. 2016;387(10024):1187–97 (http://dx.doi.org/10.1016/ s0140-6736(15)01092-2). LATERAL FLOW URINE LIPOARABINOMANNAN ASSAY (LF-LAM) FOR THE DIAGNOSIS OF ACTIVE TUBERCULOSIS IN PEOPLE LIVING WITH HIV 22
Bjerrum S, Kenu E, Lartey M, Newman MJ, Addo KK, Andersen AB et al. Diagnostic accuracy of the rapid urine lipoarabinomannan test for pulmonary tuberculosis among HIV-infected adults in Ghana–findings from the DETECT HIV-TB study. BMC Infect. Dis. 2015;15(1)(http:// dx.doi.org/10.1186/s12879-015-1151-1).
Ford N, Matteelli A, Shubber Z, Hermans S, Meintjes G, Grinsztejn B et al. TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis. J Int AIDS Soc. 2016;19(1):20714 (http://dx.doi.org/10.7448/ ias.19.1.20714).
Declaration of interests for WHO experts – forms for submission. Geneva: World Health Organization; 2019 (https://www.who.int/about/declaration-of-interests/en/).
Handbook for guideline development. Geneva: World Health Organization; 2014 (https://www. who.int/publications/guidelines/handbook_2nd_ed.pdf?ua=1).
